Specialised Therapeutics Australia Pty Ltd-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:Specialised Therapeutics Australia Pty Ltd - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8013238
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月28日
◆ページ数:28
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:オーストラリア
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Specialised Therapeutics Australia Pty Ltd (STA) is a biopharmaceutical company that develops and commercializes therapies and technologies for unmet medical needs. The company’s product portfolio includes abraxane, gliolan, oncotype dx, iclusig, oncotype dx prostate and aloxi. Its pipeline products comprise anamorelin and iluvien, among others. STA also offers services such as pharmacovigilance, investigator sponsored clinical trials, warehousing and distribution, commercialisation and marketing and local document filing, regulatory approval and registration. The company’s target therapy areas include oncology, hematology, urology, CNS and endocrinology. It partners international partner companies. The company markets its products across Australia and New Zealand. STA is headquartered in Melbourne, Victoria, Australia.

Specialised Therapeutics Australia Pty Ltd – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Specialised Therapeutics Australia Pty Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Specialised Therapeutics Australia Pty Ltd, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Specialised Therapeutics Australia Pty Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Specialised Therapeutics Australia Pty Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Specialised Therapeutics Australia Pty Ltd, Medical Devices Deals, 2011 to YTD 2017 9
Specialised Therapeutics Australia Pty Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Specialised Therapeutics Australia Pty Ltd, Pharmaceuticals & Healthcare, Deal Details 12
Partnerships 12
Alimera Sciences Enters Into Distribution Agreement With Specialised Therapeutics For Iluvien 12
Ariad Pharma Enters Into Agreement With Specialised Therapeutics To Commercialize Iclusig In Australia 13
Licensing Agreements 14
Puma Biotechnology Enters into Licensing Agreement with Specialised Therapeutics 14
Specialised Therapeutics Asia Enters into Licensing Agreement with Pharma Mar 15
Aeterna Zentaris Enters into Licensing Agreement with Specialised Therapeutics Asia 16
Specialised Therapeutics Enters into Licensing Agreement with Pharma Mar 17
Mundipharma Enters into Licensing Agreement with Specialized Therapeutics 18
Specialised Therapeutics Enters into Licensing Agreement with Pharma Mar 19
Helsinn Healthcare Enters Into Licensing Agreement With Specialised Therapeutics Australia For Anamorelin 20
Optimer Pharma Enters Into Licensing Agreement With Specialised Therapeutics For Fidaxomicin 22
Helsinn Enters Into Licensing Agreement With Specialised Therapeutics 23
Specialised Therapeutics Australia Enters Into Licensing Agreement With photonamic For Gliolan 24
Specialised Therapeutics Australia Pty Ltd – Key Competitors 25
Specialised Therapeutics Australia Pty Ltd – Key Employees 26
Specialised Therapeutics Australia Pty Ltd – Locations And Subsidiaries 27
Head Office 27
Other Locations & Subsidiaries 27
Appendix 28
Methodology 28
About GlobalData 28
Contact Us 28
Disclaimer 28

List of Tables
Specialised Therapeutics Australia Pty Ltd, Pharmaceuticals & Healthcare, Key Facts 2
Specialised Therapeutics Australia Pty Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Specialised Therapeutics Australia Pty Ltd, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Specialised Therapeutics Australia Pty Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Specialised Therapeutics Australia Pty Ltd, Deals By Therapy Area, 2011 to YTD 2017 8
Specialised Therapeutics Australia Pty Ltd, Medical Devices Deals, 2011 to YTD 2017 9
Specialised Therapeutics Australia Pty Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Alimera Sciences Enters Into Distribution Agreement With Specialised Therapeutics For Iluvien 12
Ariad Pharma Enters Into Agreement With Specialised Therapeutics To Commercialize Iclusig In Australia 13
Puma Biotechnology Enters into Licensing Agreement with Specialised Therapeutics 14
Specialised Therapeutics Asia Enters into Licensing Agreement with Pharma Mar 15
Aeterna Zentaris Enters into Licensing Agreement with Specialised Therapeutics Asia 16
Specialised Therapeutics Enters into Licensing Agreement with Pharma Mar 17
Mundipharma Enters into Licensing Agreement with Specialized Therapeutics 18
Specialised Therapeutics Enters into Licensing Agreement with Pharma Mar 19
Helsinn Healthcare Enters Into Licensing Agreement With Specialised Therapeutics Australia For Anamorelin 20
Optimer Pharma Enters Into Licensing Agreement With Specialised Therapeutics For Fidaxomicin 22
Helsinn Enters Into Licensing Agreement With Specialised Therapeutics 23
Specialised Therapeutics Australia Enters Into Licensing Agreement With photonamic For Gliolan 24
Specialised Therapeutics Australia Pty Ltd, Key Competitors 25
Specialised Therapeutics Australia Pty Ltd, Key Employees 26
Specialised Therapeutics Australia Pty Ltd, Subsidiaries 27

★海外企業調査レポート[Specialised Therapeutics Australia Pty Ltd-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • OHB System AG:企業の戦略・SWOT・財務情報
    OHB System AG - Strategy, SWOT and Corporate Finance Report Summary OHB System AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Energy World Corp Ltd (EWC):電力:M&Aディール及び事業提携情報
    Summary Energy World Corp Ltd (Energy World) is an energy company that produces and sells power and develops liquiefied natural gas projects. The company's activities include design, construction, operation, and maintenance of independent power projects, liquefied natural gas plants, and gas process …
  • L’Oreal USA, Inc.:企業の戦略的SWOT分析
    L'Oreal USA, Inc. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and serv …
  • SCSK Corporation:企業の戦略・SWOT・財務分析
    SCSK Corporation - Strategy, SWOT and Corporate Finance Report Summary SCSK Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Chevron Canada Ltd:石油・ガス:M&Aディール及び事業提携情報
    Summary Chevron Canada Ltd (CCL), a subsidiary of Chevron Corporation is an oil and gas company that refines and produces oil and natural gas products. The company explores, develops, produces and markets crude oil, natural gas and natural gas liquids. Its activities include drilling, facilities, ic …
  • Mesa Laboratories Inc (MLAB):企業の財務・戦略的SWOT分析
    Summary Mesa Laboratories Inc (Mesa) is a medical device company. It manufactures and markets validation and monitoring instruments. The company’s products include mesa biological indicators, DryCal gas flow calibrators, BGI ambient particulate sampling, DialyGuard dialysate meters, SureTorque cap t …
  • Baker Hughes, a GE Co LLC:企業の戦略的SWOT分析
    Baker Hughes, a GE Co LLC - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • Drax Group Plc (DRX):企業の財務・戦略的SWOT分析
    Drax Group Plc (DRX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • STRATEC Biomedical AG (SBS):企業の財務・戦略的SWOT分析
    Summary STRATEC Biomedical AG (STRATEC), formerly Stratec Biomedical Systems AG is a medical equipment provider that develops and manufactures automated systems for clinical diagnostics. The company provides instrumentation, data management, molecular solutions, and others. It offers data management …
  • Sempra Energy:企業の戦略・SWOT・財務情報
    Sempra Energy - Strategy, SWOT and Corporate Finance Report Summary Sempra Energy - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Saniona AB (SANION):企業の財務・戦略的SWOT分析
    Summary Saniona AB (Saniona), formerly Aniona is a research and development company that develops drugs for central nervous system diseases, autoimmune diseases, metabolic diseases and pain management. The company’s pipeline products include tesofensine, a triple monoamine reuptake inhibitor, which …
  • Nanosphere Inc-製薬・医療分野:企業M&A・提携分析
    Summary Nanosphere Inc (Nanosphere) a subsidiary of Cepheid is a medical device company that develops molecular diagnostic tests for disease detection and patient treatment. The company’s products comprise verigene system, instrumentation, bloodstream infection tests, gastrointestinal infection test …
  • Echelon Corporation (ELON):企業の財務・戦略的SWOT分析
    Echelon Corporation (ELON) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • Sensus USA Inc:企業の戦略的SWOT分析
    Sensus USA Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and service …
  • Continuus Pharmaceuticals Inc-製薬・医療分野:企業M&A・提携分析
    Summary Continuus Pharmaceuticals Inc (Continuus) is a provider of integrated continuous manufacturing technology for small molecule pharmaceuticals. The company offers an integrated continuous manufacturing technology that produces finished drug tablets from raw chemical ingredients without interru …
  • Environmental Tectonics Corp:企業の戦略・SWOT・財務分析
    Environmental Tectonics Corp - Strategy, SWOT and Corporate Finance Report Summary Environmental Tectonics Corp - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Ansaldo Energia SpA-エネルギー分野:企業M&A・提携分析
    Summary Ansaldo Energia S.p.A. (Ansaldo Energia), a subsidiary of CDP Equity SpA, is a power generation company and a supplier of power plant equipments and related services. It provides power plant equipments such as gas turbines, steam turbines, turbogenerators, and hydrogenerators used in fossil …
  • Coal India Ltd:企業のM&A・事業提携・投資動向
    Coal India Ltd - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Coal India Ltd Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestmen …
  • Kyobo Life Insurance Co Ltd:企業の戦略・SWOT・財務情報
    Kyobo Life Insurance Co Ltd - Strategy, SWOT and Corporate Finance Report Summary Kyobo Life Insurance Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • InvitroCue Ltd (IVQ)-製薬・医療分野:企業M&A・提携分析
    Summary InvitroCue Ltd (InvitroCue), formerly Bunuru Corporation Ltd is a provider of bio-analytic solutions. The company offers digital pathology services such as digitization, sample preparation, staining, computer aided diagnosis and consultation, telepathology, automated reporting and image arch …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆